151 related articles for article (PubMed ID: 31414295)
1. MRI-Based Use of Neoadjuvant Chemoradiotherapy in Rectal Carcinoma: Surgical Quality and Histopathological Outcome of the OCUM Trial.
Kreis ME; Ruppert R; Kube R; Strassburg J; Lewin A; Baral J; Maurer CA; Sauer J; Winde G; Thomasmeyer R; Stelzner S; Bambauer C; Scheunemann S; Faedrich A; Junginger T; Hermanek P; Merkel S;
Ann Surg Oncol; 2020 Feb; 27(2):417-427. PubMed ID: 31414295
[TBL] [Abstract][Full Text] [Related]
2. MRI-based indications for neoadjuvant radiochemotherapy in rectal carcinoma: interim results of a prospective multicenter observational study.
Strassburg J; Ruppert R; Ptok H; Maurer C; Junginger T; Merkel S; Hermanek P
Ann Surg Oncol; 2011 Oct; 18(10):2790-9. PubMed ID: 21509631
[TBL] [Abstract][Full Text] [Related]
3. Oncological outcome after MRI-based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial.
Ruppert R; Junginger T; Ptok H; Strassburg J; Maurer CA; Brosi P; Sauer J; Baral J; Kreis M; Wollschlaeger D; Hermanek P; Merkel S;
Br J Surg; 2018 Oct; 105(11):1519-1529. PubMed ID: 29744860
[TBL] [Abstract][Full Text] [Related]
4. Circumferential resection margin positivity after preoperative chemoradiotherapy based on magnetic resonance imaging for locally advanced rectal cancer: implication of boost radiotherapy to the involved mesorectal fascia.
Kim KH; Park MJ; Lim JS; Kim NK; Min BS; Ahn JB; Kim TI; Kim HG; Koom WS
Jpn J Clin Oncol; 2016 Apr; 46(4):316-22. PubMed ID: 26802164
[TBL] [Abstract][Full Text] [Related]
5. [Lymph node dissection after primary surgery and neoadjuvant radiochemotherapy of rectal cancer. Interim analysis of a multicenter prospective observational study (OCUM)].
Kreis ME; Maurer CA; Ruppert R; Ptok H; Strassburg J; Junginger T; Merkel S; Hermanek P
Chirurg; 2015 Dec; 86(12):1132-7. PubMed ID: 26223668
[TBL] [Abstract][Full Text] [Related]
6. Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer.
Konishi T; Shinozaki E; Murofushi K; Taguchi S; Fukunaga Y; Nagayama S; Fujimoto Y; Akiyoshi T; Nagasaki T; Suenaga M; Chino A; Kawachi H; Yamamoto N; Ishikawa Y; Oguchi M; Ishizuka N; Ueno M; Yamaguchi K
Ann Surg Oncol; 2019 Aug; 26(8):2507-2513. PubMed ID: 30963400
[TBL] [Abstract][Full Text] [Related]
7. Nodal staging with MRI after neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: a fast and reliable method.
Crimì F; Cabrelle G; Campi C; Schillaci A; Bao QR; Pepe A; Spolverato G; Pucciarelli S; Vernuccio F; Quaia E
Eur Radiol; 2024 May; 34(5):3205-3214. PubMed ID: 37930408
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
[TBL] [Abstract][Full Text] [Related]
9. Significance of MRI in rectal carcinoma therapy optimization - correlation of preoperative T- and N-staging with definitive histopathological findings.
Danihel L; Danihel L; Rajcok M; Mosna K; Belan V; Varga I; Schnorrer M
Neoplasma; 2019 May; 66(3):494-498. PubMed ID: 30793609
[TBL] [Abstract][Full Text] [Related]
10. MAGNETIC RESONANCE IMAGING TO EVALUATE NEOADJUVANT THERAPY EFFECTS ON RECTAL CARCINOMA.
Sofić A; Vukobrat-Bijedić Z; Husić-Selimović A; Šehović N; Buija D; Eminagić D; Banjin M; Đuran A
Acta Clin Croat; 2015 Sep; 54(3):303-8. PubMed ID: 26666099
[TBL] [Abstract][Full Text] [Related]
11. [Spincter preservation after selective chemoradiotherapy of rectal cancer. Interim results of the OCUM study].
Baral J; Schön MR; Ruppert R; Ptok H; Strassburg J; Brosi P; Kreis ME; Lewin A; Sauer J; Sawicki S; Schiffmann L; Winde G; Junginger T; Merkel S; Hermanek P
Chirurg; 2015 Dec; 86(12):1138-44. PubMed ID: 26347011
[TBL] [Abstract][Full Text] [Related]
12. MRI-detected tumor deposits in cT3 and cT4 rectal cancer following neoadjuvant chemoradiotherapy.
Que YT; Chen Y; Yang XY; Ma YR; Liu YY; Wen ZQ; Lu BL; Wu XH; Zhang ZW; Wu YZ; Yu SP; Yuan JP
Eur Radiol; 2024 May; 34(5):2963-2973. PubMed ID: 37840101
[TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
14. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
[TBL] [Abstract][Full Text] [Related]
15. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
[TBL] [Abstract][Full Text] [Related]
16. [Quality indicators of diagnosis and therapy in MRI-based neoadjuvant radiochemotherapy for rectal cancer - interim analysis of a Prospective Multicentre Observational Study (OCUM)].
Ruppert R; Ptok H; Strassburg J; Maurer CA; Junginger T; Merkel S; Hermanek P
Zentralbl Chir; 2013 Dec; 138(6):630-5. PubMed ID: 22700247
[TBL] [Abstract][Full Text] [Related]
17. Use of Preoperative Magnetic Resonance Imaging to Select Patients with Rectal Cancer for Neoadjuvant Chemoradiation--Interim Analysis of the German OCUM Trial (NCT01325649).
Kreis ME; Ruppert R; Ptok H; Strassburg J; Brosi P; Lewin A; Schön MR; Sauer J; Junginger T; Merkel S; Hermanek P;
J Gastrointest Surg; 2016 Jan; 20(1):25-32; discussion 32-3. PubMed ID: 26556476
[TBL] [Abstract][Full Text] [Related]
18. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
[TBL] [Abstract][Full Text] [Related]
19. MRI-defined T3, clear mesorectal fascia mid-low rectal cancer: is neoadjuvant treatment necessary?
Zeng Z; Li Z; Luo S; Huang L; Liang Z; Zheng X; Li W; Xiong L; Liu H; Kang L
J Gastroenterol Hepatol; 2024 May; 39(5):858-867. PubMed ID: 38225773
[TBL] [Abstract][Full Text] [Related]
20. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
[Next] [New Search]